A Mycobacterium marinum mel2 mutant is defective for growth in macrophages that produce reactive oxygen and reactive nitrogen species

Infection and Immunity

Volumn 75, Issue 1, 2007, Pages 127-134

  Subbian, Selvakumar ^a   Mehta, Parmod K ^a   Cirillo, Suat L G ^a   Bermudez, Luiz E ^b   Cirillo, Jeffrey D ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE INHIBITOR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIUM MUTANT; CONTROLLED STUDY; DISEASE MODEL; FOOT PAD; GENE LOCUS; IMMUNOPATHOGENESIS; MACROPHAGE; MEL2 GENE; MELF GENE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM MARINUM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; BACTERIAL PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; GENES, BACTERIAL; MACROPHAGES; MICE; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM MARINUM; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 33846020581     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01000-06     Document Type: Article

References (52)

1. Adams, L. B., M. C. Dinauer, D. E. Morgenstern, and J. L. Krahenbuhl. 1997. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuber. Lung Dis. 78:237-246.
2. Adams, L. B., S. G. Franzblau, Z. Vavrin, J. B. Hibbs, Jr., and J. L. Krahenbuhl. 1991. L-Arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae. J. Immunol. 147:1642-1646.
3. Bailey, J. P., Jr., S. J. Stevens, W. M. Bell, H. G. Mealing, Jr., D. H. Loebl, and E. H. Cook. 1982. Mycobacterium marinum infection. A fishy story. JAMA 247:1314.
4. Barker, L. P., K. M. George, S. Falkow, and P. L. C. Small. 1997. Differential trafficking of live and dead Mycobacterium marinum organisms in macrophages. Infect. Immun. 65:1497-1504.
5. Brunelli, L., J. P. Crow, and J. S. Beckman. 1995. The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli. Arch. Biochem. Biophys. 316:327-334.
6. Casanova, J. L., and L. Abel. 2002. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 20:581-620.
7. Chan, J., K. Tanaka, D. Carroll, J. Flynn, and B. R. Bloom. 1995. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 63:736-740.
8. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122.
9. Clark, H. F., and C. C. Shepard. 1963. Effect of environmental temperatures on infection with Mycobacterium marinum (Balnei) of mice and a number of poikilothermic species. J. Bacteriol. 86:1057-1069.
10. Clark, R. B., H. Spector, D. M. Friedman, K. J. Oldrati, C. L. Young, and S. C. Nelson. 1990. Osteomyelitis and synovitis produced by Mycobactenurn marinum in a fisherman. J. Clin. Microbiol. 28:2570-2572.
11. Cochrane, R. G., and T. F. Davey. 1964. Leprosy in theory and practice, 2nd ed. John Wright and Sons Ltd., Bristol, United Kingdom.
12. Collins, C. H., J. M. Grange, W. C. Noble, and M. D. Yates. 1985. Mycobacterium marinum infections in man. J. Hyg. 94:135-149.
13. Collins, F. M., V. Montalbine, and N. E. Morrison. 1975. Growth and immunogenicity of photochromogenic strains of mycobacteria in the footpads of normal mice. Infect. Immun. 11:1079-1087.
14. Darwin, K. H., S. Ehrt, J. C. Gutierrez-Ramos, N. Weich, and C. F. Nathan. 2003. The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science 302:1963-1966.
15. Darwin, K. H., and C. F. Nathan. 2005. Role for nucleotide excision repair in virulence of Mycobacterium tuberculosis. Infect. Immun. 73:4581-4587.
16. Dobos, K. M., F. D. Quinn, D. A. Ashford, C. R. Horsburgh, and C. H. King. 1999. Emergence of a unique group of necrotizing mycobacterial diseases. Emerg. Infect. Dis. 5:367-378.
17. Douglas, T., D. S. Daniel, B. K. Parida, C. Jagannath, and S. Dhandayuthapani. 2004. Methionine sulfoxide reductase A (MsrA) deficiency affects the survival of Mycobacterium smegmatis within macrophages. J. Bacteriol. 186:3590-3598.
18. Ehrt, S., D. Schnappinger, S. Bekiranov, J. Drenkow, S. Shi, T. R. Gingeras, T. Gaasterland, G. Schoolnik, and C. Nathan. 2001. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 194:1123-1140.
19. Ehrt, S., M. U. Shiloh, J. Ruan, M. Choi, S. Gunzburg, C. Nathan, Q. Xie, and L. Riley. 1997. A novel antioxidant gene from Mycobacterium tuberculosis. J. Exp. Med. 186:1885-1896.
20. El-Etr, S. H., S. Subbian, S. L. Cirillo, and J. D. Cirillo. 2004. Identification of two Mycobacterium marinum loci that affect interactions with macrophages. Infect. Immun. 72:6902-6913.
21. El-Etr, S. H., L. Van, and J. D. Cirillo. 2001. Fish monocytes as a model for mycobacterial host-pathogen interactions. Infect. Immun. 69:7310-7317.
22. Fenton, M. J., and M. W. Vermeulen. 1996. Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect. Immun. 64:683-690.
23. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
24. Gluckman, S. J. 1995. Mycobacterium marinum. Clin. Dermatol. 13:273-276.
25. Green, L. C., D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126:131-138.
26. Hibbs, J. B., Jr., R. R. Taintor, and Z. Vavrin. 1987. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 235:473-476.
27. Huminer, D., S. D. Pitlik, C. Block, L. Kaufman, S. Amit, and J. B. Rosenfeld. 1986. Aquarium-borne Mycobacterium marinum skin infection. Report of a case and review of the literature. Arch. Dermatol. 122:698-703.
28. Ischiropoulos, H., L. Zhu, and J. S. Beckman. 1992. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298:446-451.
29. Koppenol, W. H., J. J. Moreno, W. A. Pryor, H. Ischiropoulos, and J. S. Beckman, 1992. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem. Res. Toxicol. 5:834-842.
30. Lyzen, R., and G. Wegrzyn. 2005. Sensitivity of dark mutants of various strains of luminescent bacteria to reactive oxygen species. Arch. Microbiol. 183:203-208.
31. MacMicking, J. D., R. J. North, R. LaCourse, J. S. Mudgett, S. K. Shah, and C. F. Nathan. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94:5243-5248.
32. Meyer, A. H., S. F. Gabby Krens, I. A. Medina Rodriguez, S. He, W. Bitter, B. Ewa Snaar-Jagalska, and H. P. Spaink. 2004. Expression analysis of the Toll-like receptor and TIR domain adaptor families of zebrafish. Mol. Immunol. 40:773-783.
33. Mor, N. 1985. Multiplication of Mycobacterium marinum within phagolysosomes of murine macrophages. Infect. Immun. 48:850-852.
34. Nathan, C., and M. U. Shiloh. 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 97:8841-8848.
35. Ng, V. H., J. S. Cox, A. O. Sousa, J. D. MacMicking, and J. D. McKinney. 2004. Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol. Microbiol. 52:1291-1302.
36. Pagan-Ramos, E., S. S. Master, C. L. Pritchett, R. Reimschuessel, M. Trucksis, G. S. Timmins, and V. Deretic. 2006. Molecular and physiological effects of mycobacterial oxyR inactivation. J. Bacteriol. 188:2674-2680.
37. Pascopella, L., F. M. Collins, J. M. Martin, M. H. Lee, G. F. Hatfull, C. K. Stover, B. R. Bloom, and W. R. Jacobs, Jr. 1994. Use of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment associated with virulence. Infect. Immun. 62:1313-1319.
38. Pick, E. 1986. Microassays for superoxide and hydrogen peroxide production and nitroblue tetrazolium reduction using an enzyme immunoassay microplate reader. Methods Enzymol. 132:407-421.
39. Piddington, D. L., F. C. Fang, T. Laessig, A. M. Cooper, I. M. Orme, and N. A. Buchmeier. 2001. Cu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst. Infect. Immun. 69:4980-4987.
40. Ramakrishnan, L., and S. Falkow. 1994. Mycobacterium marinum persists in cultured mammalian cells in a temperature-restricted fashion. Infect. Immun. 62:3222-3229.
41. Rees, J.-F., B. De Wergifosse, O. Noiset, M. Dubuisson, B. Janssens, and E. M. Thompson. 1998. The origins of marine bioluminescence: turning oxygen defence mechanisms into deep-sea communication tools. J. Exp. Biol. 201:1211-1221.
42. Ruan, J., G. St. John, S. Ehrt, L. Riley, and C. Nathan. 1999. noxR3, a novel gene from Mycobacterium tuberculosis, protects Salmonella typhimurium from nitrosative and oxidative stress. Infect. Immun. 67:3276-3283.
43. Savage, M. V., and G. L. Brengelmann. 1996. Control of skin blood flow in the neutral zone of human body temperature regulation. J. Appl. Physiol. 80:1249-1257.
44. Shepard, C. C. 1958. A comparison of the growth of selected mycobacteria in HeLa, monkey kidney and human amnion cells in tissue culture. J. Exp. Med. 107:237-250.
45. Shepard, C. C. 1957. Growth characteristics of tubercle bacilli and certain other mycobacteria in HeLa cells. J. Exp. Med. 105:39-48.
46. Shi, S., and S. Ehrt. 2006. Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis. Infect. Immun. 74:56-63.
47. St. John, G., N. Brot, J. Ruan, H. Erdjument-Bromage, P. Tempst, H. Weissbach, and C. Nathan. 2001. Peptide methionine sulfoxide reductase from Escherichia coli and Mycobacterium tuberculosis protects bacteria against oxidative damage from reactive nitrogen intermediates. Proc. Natl. Acad. Sci. USA 98:9901-9906.
48. Stover, C. K., V. F. de la Cruz, T. R. Fuerst, J. E. Burlein, L. A. Benson, L. T. Bennet, G. P. Bansal, J. F. Young, M. H. Lee, G. F. Hatfull, S. B. Snapper, R. G. Barletta, W. R. Jacobs, Jr., and B. R. Bloom. 1991. New use of BCG for recombinant vaccines. Nature 351:456-460.
49. 2: the evolutionary origin of luciferase and source of endogenous light emission. Biochim. Biophys. Acta 1141:297-302.
50. Wilson, T., G. W. de Lisle, J. A. Marcinkeviciene, J. S. Blanchard, and D. M. Collins. 1998. Antisense RNA to ahpC, an oxidative stress defence gene involved in isoniazid resistance, indicates that AhpC of Mycobacterium bovis has virulence properties. Microbiology 144:2687-2695.
51. Yu, K., C. Mitchell, Y. Xing, R. S. Magliozzo, B. R. Bloom, and J. Chan. 1999. Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion. Tuber. Lung Dis. 79:191-198.
52. Zhu, L., C. Gunn, and J. S. Beckman. 1992. Bactericidal activity of peroxynitrite. Arch. Biochem. Biophys. 298:452-457.